Skip Navigation Hotkeys

Search and Service

Assistive Product PARI Compact2 Junior

Product Type:

Nozzle nebulizer

Indications:

  • Asthma
  • Allergies
  • Bronchitis
  • Chronic obstructive bronchitis (COPD)
  • Preventive care of the airways

Description:

The PARI Compact2 Junior is a further development of the PARI Compact Junior. The device is designed for babies and toddlers up to the age of three. A soft silicone BABY mask with BABY angle ensures comfortable therapy in a sitting or lounger position. The PARI LC PLUS Baby nebulizer delivers particularly fine droplets for the small airways of babies and toddlers.

Features / Components:

  • for babies and toddlers up to 3 years
  • medication nebulizer for the lower airways
  • more powerful compressor than the previous model for short inhalation times
  • basic device with mains cable
  • with PARI LC PLUS nebuliser
  • with mouthpiece
  • with size 2 baby mask
  • with connection tube
  • with contra-angle handpiece

Price (without guarantee):

The price is available on request from the manufacturer / distributor.

SHI-Number:

SHI-Medical Technical Aids Register | 14.24.01.0159

Product Information from the Manufacturer / Distributor:

Further Product Details

Further Information

REHADAT does not sell any products

Please contact the manufacturer or distributor.

Manufacturer:

PARI Medical Holding GmbH
Moosstr. 3
82319 Starnberg
Germany Telephone: 08151 279-0 Email: info@pari.de Homepage: https://www.pari.com

Distributor:

PARI Medical Holding GmbH
Moosstr. 3
82319 Starnberg
Germany Telephone: 08151 279-0 Email: info@pari.de Homepage: https://www.pari.com

Technical Data:

Weight: 1.55 kg
Dimensions (W x H x D): 18.5 x 13 x 15 cm
Voltage: 220-240 V AC, 50 Hz
Operating noise: approx. 56 dB(A)
Compressor flow: 4.1 l/min
Pharmaceutical central number: 13868438

Keywords

ISO

Search for similar prodcuts in REHADAT:
Search for similar products in EASTIN throughout Europe:

ICF Items

Reference Number:

Hil135653


Source :

DIAS


Last Update: 12 Mar 2024